In 2020, Credo Biomedical debuted its rapid flu test in the international arena. This series looks at the challenges that fledgling ventures face if they choose to go global and why some companies take the leap. Follow the founders of each company as they navigate key goals and examine whether they succeed in meeting the real-time challenges of product development and sales that they set for themselves.
Pets can’t tell us what’s wrong, but their biology can.
April 13, 2025
In vet care, speed and accuracy save lives—no time to wait or guess. QubeMDx+™ delivers fast, lab quality PCR results in 20 minutes at the
